22 results
REBEL Review 4 & 5: Paralytic & Vasopressor Dosing 

Paralytic Agents:
 - Succinylcholine (Depolarizing Agent)
Paralytic Agents ... resuscitation #table ... #criticalcare # ... pharmacology #dosing ... #medications #Comparison
Direct-acting oral anticoagulants (DOACs) for VTE treatment and prevention - Comparison Table

#DOAC #Anticoagulants #Anticoagulation #VTE #Management
treatment and prevention ... - Comparison Table ... Anticoagulation #VTE #Management ... #Pharmacology # ... Comparison #Table
Useful Intravenous Antihypertensive Agents
- Nicardipine
- Clevidipine
- Labetalol
- Esmolol
- Nitroglycerin

Dr. Josh Farkas https://twitter.com/PulmCrit

#Antihypertensive #Agents #Hypertensive #Emergency #Pharmacology
Antihypertensive Agents ... Hypertensive #Emergency #Pharmacology ... #Table #Intravenous ... #IV #CriticalCare ... BloodPressure #Management
Comparison of anti-diabetic or anti-hyperglycemic agents

There are numerous anti-hyperglycemic agents available to manage Type 2 diabetes.
Comparison of anti-diabetic ... anti-hyperglycemic agents ... #pharmacology #pharmacotherapy ... #table #comparison ... #management #medications
Intern Pocket Cards - Pharmacologic Pain Management Options
Anti-inflammatory:
 • Acetaminophen (24 hours: < 3-4g in healthy
Pocket Cards - Pharmacologic ... Pain Management ... • Neuropathic agents ... #agents #internship ... #guide #comparison
Spectrum of activity for systemic antifungal agents
Antifungals: 5FC, flucytosine; AMB, amphotericin B; ANI, anidulafungin; CAS, caspofungin;
systemic antifungal agents ... fluconazole; ISA ... parapsilosis, Candida tropicalis ... #antibiogram #management ... #pharmacology #
IDSA Recommendations for Preventing and Managing Microsporidiosis in HIV-AIDS
Preventing Chronic Microsporidiosis:
 • Because chronic microsporidiosis occurs
IDSA Recommendations ... for Preventing ... Microsporidiosis #IDSA ... #management #opportunistic ... infections #HIVAIDS #pharmacology
IDSA 2017 CDiff Guidelines - Table 7. Potential Treatment Agents for Treatment of the Primary Clostridium difficile
IDSA 2017 CDiff ... Guidelines - Table ... Potential Treatment Agents ... infection Episode #Pharmacology ... #Management #CDiff
IDSA Recommendations for Preventing and Managing Cryptosporidiosis in HIV-AIDS
Preventing Chronic Cryptosporidiosis:
 • Because chronic cryptosporidiosis occurs
IDSA Recommendations ... for Preventing ... anti-diarrheal agent ... Cryptosporidiosis #IDSA ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... chew, or crush tablet ... #Prevention #Treatment ... #management #opportunistic ... infections #HIVAIDS #pharmacology